Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 2
2006 1
2007 3
2008 5
2011 1
2012 2
2014 1
2015 3
2016 2
2017 4
2018 4
2019 7
2020 4
2021 9
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
The prodromal microbiome.
Scheperjans F. Scheperjans F. Mov Disord. 2018 Jan;33(1):5-7. doi: 10.1002/mds.27197. Epub 2017 Oct 30. Mov Disord. 2018. PMID: 29082565 No abstract available.
Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. Scheperjans F, et al. Mov Disord. 2015 Mar;30(3):350-8. doi: 10.1002/mds.26069. Epub 2014 Dec 5. Mov Disord. 2015. PMID: 25476529
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis.
Kleine Bardenhorst S, Cereda E, Severgnini M, Barichella M, Pezzoli G, Keshavarzian A, Desideri A, Pietrucci D, Aho VTE, Scheperjans F, Hildebrand F, Weis S, Egert M, Karch A, Vital M, Rübsamen N. Kleine Bardenhorst S, et al. Among authors: scheperjans f. Eur J Neurol. 2023 Nov;30(11):3581-3594. doi: 10.1111/ene.15671. Epub 2023 Jan 18. Eur J Neurol. 2023. PMID: 36593694 Review.
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial.
Huttunen HJ, Booms S, Sjögren M, Kerstens V, Johansson J, Holmnäs R, Koskinen J, Kulesskaya N, Fazio P, Woolley M, Brady A, Williams J, Johnson D, Dailami N, Gray W, Levo R, Saarma M, Halldin C, Marjamaa J, Resendiz-Nieves J, Grubor I, Lind G, Eerola-Rautio J, Mertsalmi T, Andréasson M, Paul G, Rinne J, Kivisaari R, Bjartmarz H, Almqvist P, Varrone A, Scheperjans F, Widner H, Svenningsson P. Huttunen HJ, et al. Among authors: scheperjans f. Mov Disord. 2023 Jul;38(7):1209-1222. doi: 10.1002/mds.29426. Epub 2023 May 22. Mov Disord. 2023. PMID: 37212361 Clinical Trial.
The Gut and Parkinson's Disease: Hype or Hope?
Scheperjans F, Derkinderen P, Borghammer P. Scheperjans F, et al. J Parkinsons Dis. 2018;8(s1):S31-S39. doi: 10.3233/JPD-181477. J Parkinsons Dis. 2018. PMID: 30584161 Free PMC article. Review.
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
Xie A, Ensink E, Li P, Gordevičius J, Marshall LL, George S, Pospisilik JA, Aho VTE, Houser MC, Pereira PAB, Rudi K, Paulin L, Tansey MG, Auvinen P, Brundin P, Brundin L, Labrie V, Scheperjans F. Xie A, et al. Among authors: scheperjans f. Mov Disord. 2022 Aug;37(8):1644-1653. doi: 10.1002/mds.29128. Epub 2022 Jun 20. Mov Disord. 2022. PMID: 35723531 Free PMC article.
56 results